Literature DB >> 1321269

Epstein-Barr virus BZLF1 transactivator is a negative regulator of Jun.

H Sato1, H Takeshita, M Furukawa, M Seiki.   

Abstract

The Epstein-Barr virus BZLF1 protein that can induce the lytic cycle in latently infected cells is a transcription factor partially homologous to Fos and binds not only the canonical TPA (tetradecanoyl phorbol acetate)-responsive element (TRE) site but also sequences deviating from the TRE consensus sequence. Thus, expression of cellular genes regulated by AP-1, including the autoregulated AP-1 family, should be affected by BZLF1. However, induction of only Fos by BZLF1 was observed in a gel mobility shift assay using an oligonucleotide probe containing the TRE sequence and the antibody against Fos protein. The c-jun promoter, which contains a binding site for Jun and BZLF1, was stimulated by Jun but not by BZLF1. Furthermore, BZLF1 inhibited stimulation of the c-jun promoter by Jun. Jun together with Fos effectively activated the collagenase promoter that contains a single TRE site. However, not only was BZLF1 unable to stimulate the collagenase promoter, but it also inhibited activation by Jun and Fos. On the other hand, BZLF1 stimulated constructs containing multimeric binding sites. These results and those of previous studies of Epstein-Barr virus promoters regulated by BZLF1 indicate that BZLF1 requires adjacent multiple DNA-binding sites for cooperative interaction to function as a transactivator and to repress the activation by Jun of promoters containing a single TRE site. This suggests that BZLF1 evolved to confer distinct regulatory patterns upon viral target genes and cellular AP-1-responsive genes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321269      PMCID: PMC241299     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region.

Authors:  P Angel; I Baumann; B Stein; H Delius; H J Rahmsdorf; P Herrlich
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

2.  Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells.

Authors:  M Biggin; M Bodescot; M Perricaudet; P Farrell
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

3.  Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus.

Authors:  W Hammerschmidt; B Sugden
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

4.  trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment.

Authors:  K Takada; N Shimizu; S Sakuma; Y Ono
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

5.  The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1.

Authors:  P Angel; K Hattori; T Smeal; M Karin
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

6.  Oncogene jun encodes a sequence-specific trans-activator similar to AP-1.

Authors:  P Angel; E A Allegretto; S T Okino; K Hattori; W J Boyle; T Hunter; M Karin
Journal:  Nature       Date:  1988-03-10       Impact factor: 49.962

7.  Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells.

Authors:  M H Kryszke; J Piette; M Yaniv
Journal:  Nature       Date:  1987 Jul 16-22       Impact factor: 49.962

8.  Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun.

Authors:  R Chiu; P Angel; M Karin
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

9.  The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites.

Authors:  G Urier; M Buisson; P Chambard; A Sergeant
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

10.  Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos.

Authors:  P J Farrell; D T Rowe; C M Rooney; T Kouzarides
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

View more
  8 in total

1.  Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta.

Authors:  J Lu; S Y Chen; H H Chua; Y S Liu; Y T Huang; Y Chang; J Y Chen; T S Sheen; C H Tsai
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator.

Authors:  T Yoshizaki; H Sato; S Murono; J S Pagano; M Furukawa
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

3.  Initiation of lytic DNA replication in Epstein-Barr virus: search for a common family mechanism.

Authors:  Andrew J Rennekamp; Paul M Lieberman
Journal:  Future Virol       Date:  2010-01       Impact factor: 1.831

Review 4.  Modeling mucosal cell-associated HIV type 1 transmission in vitro.

Authors:  Deborah J Anderson
Journal:  J Infect Dis       Date:  2014-12-15       Impact factor: 5.226

5.  Phosphorylation of Epstein-Barr virus ZEBRA protein at its casein kinase 2 sites mediates its ability to repress activation of a viral lytic cycle late gene by Rta.

Authors:  Ayman S El-Guindy; George Miller
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  The lytic transition of Epstein-Barr virus is imitated by recombinant B-cells.

Authors:  M Marschall; P Alliger; F Schwarzmann; C Bogedain; M Brand; B Reichelt; G Glaser; H Wolf
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

7.  Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication.

Authors:  Ayumi Kudoh; Masatoshi Fujita; Tohru Kiyono; Kiyotaka Kuzushima; Yutaka Sugaya; Shunji Izuta; Yukihiro Nishiyama; Tatsuya Tsurumi
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

8.  Mechanism of activation of the BNLF2a immune evasion gene of Epstein-Barr virus by Zta.

Authors:  Rajaei Almohammed; Kay Osborn; Sharada Ramasubramanyan; Ijiel Barak Naranjo Perez-Fernandez; Anja Godfrey; Erika J Mancini; Alison J Sinclair
Journal:  J Gen Virol       Date:  2018-03-26       Impact factor: 3.891

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.